Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Delivers No Evidence FDA Knew Of "Phantom" Recall - Congressional Staff

This article was originally published in The Tan Sheet

Executive Summary

Johnson & Johnson failed to provide proof that FDA acknowledged the firm's plan for a "phantom" recall of a Motrin product, according to Capitol Hill staff
Advertisement

Related Content

J&J Settlement With States Not Likely To Be Precedent In OTC Space
J&J Settlement With States Not Likely To Be Precedent In OTC Space
J&J Directors Find Root Causes But Little Blame For OTC Quality Issues
Issa Scolds FDA On Failure To Inspect McNeil Plant
FDA Enforces Consent Decree Over J&J/McNeil's OTC Manufacturing
J&J Recalled To Capitol Hill As Besieged Consumer Group Chair Retires
J&J Recalled To Capitol Hill As Besieged Consumer Group Chair Retires
McNeil Recalls Cut J&J's Profits, Draw U.S. Attorney's Subpoena
Consumer Lawsuits Allege J&J Concealed OTC Defects
FDA To Toughen OTC Oversight, Seek New Authority In Wake Of J&J Recalls

Topics

Advertisement
UsernamePublicRestriction

Register

PS104537

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel